Today’s psychedelics researchers still have to deal with the fallout of the decadeslong freeze on research. Listen to ‘The Conversation Weekly’ podcast.
Pinpointing the molecular targets behind the subjective effects of psychedelic drugs could help clinicians and researchers better treat psychiatric conditions.
Research shows therapeutic psilocybin to be a safe and effective antidote to end-of-life anxiety and depression. Does prohibition therefore violate our right to “life, liberty and security?”
To know the real promise of psychedelic substances like LSD, mushrooms and MDMA, researchers must embrace the principles and practise of ‘open science.’